SCHEMBL7210449

SCHEMBL7210449

O=Cc1ccc(N2c3ccccc3Sc3ccccc32)cc1

nearest known ligand 0.54

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.54
BCHE P06276 6/20 0.43
MAOA P21397 1/20 0.42
ACHE P22303 2/20 0.41
NOX1 Q9Y5S8 1/20 0.41
ALDH1A1 P00352 5/20 0.40
CYP2A6 P11509 1/20 0.40
TRIM24 O15164 1/20 0.39
TRIM33 Q9UPN9 1/20 0.39
KDM4E B2RXH2 3/20 0.39
MAPK1 P28482 1/20 0.39
POLB P06746 1/20 0.38
ATM Q13315 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20008789 0.87 HDAC6 (0.53) HDAC6BCHEACHENOX1MAPK1
SCHEMBL2496482 0.85 HDAC6 (0.44) HDAC6BCHEMAOAACHENOX1
SCHEMBL12190901 0.84 HDAC6 (0.62) HDAC6BCHEMAOAACHENOX1
SCHEMBL29851224 0.84 HDAC6 (0.62) HDAC6BCHEMAOAACHENOX1
SCHEMBL9718477 0.82 HDAC6 (0.50) HDAC6BCHEMAOAACHENOX1
SCHEMBL29229302 0.82 TRIM24 (0.39) HDAC6ALDH1A1TRIM24TRIM33KDM4E
SCHEMBL30932461 0.82 TRIM24 (0.39) HDAC6ALDH1A1TRIM24TRIM33KDM4E
SCHEMBL2498958 0.79 HDAC6 (0.38) HDAC6ALDH1A1CYP2A6KDM4EMAPK1
SCHEMBL15470447 0.79 HDAC6 (0.57) HDAC6BCHEMAOAACHENOX1
SCHEMBL342426 0.78 HDAC6 (0.56) HDAC6BCHEMAOAACHENOX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121574101-A Preparation method and application of quinazoline compound 厦门大学 2026-02-27 CN disclosed
CN-117886749-A Lithium ion battery anode material, and preparation method and application thereof 天津大学 2024-04-16 CN disclosed
CN-116947737-A Preparation and application of tetraphenyl ethylene-chalcone derivative 三峡大学 2023-10-27 CN disclosed
US-10937970-B2 Compound and photoelectric device, image sensor and electronic device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2021-03-02 US disclosed
US-20190131541-A1 COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2019-05-02 US disclosed
CN-102617508-B N-(4-formylphenyl)-phenothiazine and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2014-03-12 CN disclosed
CN-102617508-B N-(4-formylphenyl)-phenothiazine and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2014-03-12 CN disclosed
CN-102617508-A N-(4-formylphenyl)-phenothiazine and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2012-08-01 CN disclosed
CN-102617508-A N-(4-formylphenyl)-phenothiazine and preparation method thereof UNIV SHAANXI SCIENCE & TECH 2012-08-01 CN disclosed
US-6617053-B2 High luminous efficiency and a long life CHISSO CORPORATION (JP) 2003-09-09 US disclosed
US-20020027415-A1 Organic electroluminescent device containing dithiafulvene derivative CHISSO CORPORATION (JP) 2002-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10937970-B2 Compound and photoelectric device, image sensor and electronic device including the same NCS1, CYP19A1, CYP1A1 HDAC6 4562/4885BCHE 778/4885MAOA 875/4885
US-20190131541-A1 COMPOUND AND PHOTOELECTRIC DEVICE, IMAGE SENSOR AND ELECTRONIC DEVICE INCLUDING THE SAME NCS1, CYP19A1, CYP1A1 HDAC6 4562/4885BCHE 778/4885MAOA 875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.